N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin

References

• AMIDI, M., MASTROBATTISTA, E., JISKOOT, W. & HENNINK, W. E. (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev, 62, 59–82.
   PubMed Web of Science ®Google Scholar
• CHENG, H. C., CHANG, C. Y., HSIEH, F. I., YEH, J. J., CHIEN, M. Y., PAN, R. N., DENG, M. C. & LIU, D. Z. (2011) Effects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccine. J Microencapsul, 28, 55–61.
   PubMed Web of Science ®Google Scholar
• IWANAGA, K., ONO, H., NARIOKA, K., MORIMOTO, K., KAKEMI, M., YAMASHITA, S., NANGO, M. & OKU, N. (1997) Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract International Journal of Pharmaceutics, 157, 8.
   Google Scholar
• JINTAPATTANAKIT, A., JUNYAPRASERT, V. B. & KISSEL, T. (2009) The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake. J Pharm Sci, 98, 4818–30.
   PubMed Web of Science ®Google Scholar
• JONKER-VENTER, C., SNYMAN, D., JANSE VAN RENSBURG C., JORDAAN, E., SCHULTZ, C., STEENEKAMP, J. H., HAMMAN J. H. & KOTZE, A. F. (2006) Low molecular weight quaternised chitosan (11): in vitro assessment of absorption enhancing properties. Pharmazie, 61, 301–5.
   PubMed Web of Science ®Google Scholar
• JONKER, C., HAMMAN, J. H. & KOTZE, A. F. (2002) Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int J Pharm, 238, 205–13.
   PubMed Web of Science ®Google Scholar
• KATAS, H. & ALPAR, H. O. (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release, 115, 216–25.
   PubMed Web of Science ®Google Scholar
• KOTZE, A. F., LUESSEN, H. L., DE LEEUW, B. J., DE BOER A. G., VERHOEF J. C. & JUNGINGER, H. E. (1998) Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release, 51, 35–46.
   PubMed Web of Science ®Google Scholar
• KOTZE, A. F., LUESSEN, H. L., DE LEEUW B. J., DE BOER B. G., VERHOEF, J. C. & JUNGINGER, H. E. (1997) N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res, 14, 1197–202.
   PubMed Web of Science ®Google Scholar
• MAKHLOF, A., FUJIMOTO, S., TOZUKA, Y. & TAKEUCHI, H. (XXXX) In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur J Pharm Biopharm.
   Web of Science ®Google Scholar
• MAO, S., SUN, W. & KISSEL, T. (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev, 62, 12–27.
   PubMed Web of Science ®Google Scholar
• POLNOK, A., BORCHARD, G., VERHOEF, J. C., SARISUTA, N. & JUNGINGER, H. E. (2004) Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm, 57, 77–83.
   PubMed Web of Science ®Google Scholar
• SIEVAL, A. B., THANOU, M., KOTZ, A. F., VERHOEF, J. C., BRUSSEE, J. & JUNGINGER, H. E. (1998) Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohydr. Pollym, 36, 157–165.
   Web of Science ®Google Scholar
• SINSWAT, P. & TENGAMNUAY, P. (2003) Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins. Int J Pharm, 257, 15–22.
   PubMed Web of Science ®Google Scholar
• SMART, J. D. (2005) The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev, 57, 1556–68.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI, H., MATSUI, Y., SUGIHARA, H., YAMAMOTO, H. & KAWASHIMA, Y. (2005a) Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm, 303, 160–70.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI, H., MATSUI, Y., YAMAMOTO, H. & KAWASHIMA, Y. (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release, 86, 235–42.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI, H., THONGBORISUTE, J., MATSUI, Y., SUGIHARA, H., YAMAMOTO, H. & KAWASHIMA, Y. (2005b) Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev, 57, 1583–94.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI, H., YAMAMOTO, H., NIWA, T., HINO, T. & KAWASHIMA, Y. (1996) Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res, 13, 896–901.
   PubMed Web of Science ®Google Scholar
• THANOU, M. M., KOTZE, A. F., SCHARRINGHAUSEN, T., LUESSEN, H. L., DE BOER A. G., VERHOEF, J. C. & JUNGINGER, H. E. (2000) Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release, 64, 15–25.
   PubMed Web of Science ®Google Scholar
• THONGBORISUTE, J. & TAKEUCHI, H. (2008) Evaluation of mucoadhesiveness of polymers by BIACORE method and mucin-particle method. Int J Pharm, 354, 204–9.
   PubMed Web of Science ®Google Scholar
• THONGBORISUTE, J., TSURUTA, A., KAWABATA, Y. & TAKEUCHI, H. (2006) The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. J Drug Target, 14, 147–54.
   PubMed Web of Science ®Google Scholar
• VAN DER MERWE S. M., VERHOEF, J. C., VERHEIJDEN, J. H., KOTZE, A. F. & JUNGINGER, H. E. (2004) Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm, 58, 225–35.
   PubMed Web of Science ®Google Scholar
• WERLE, M., MAKHLOF, A. & TAKEUCHI, H. (2010) Carbopol-lectin conjugate coated liposomes for oral peptide delivery. Chem Pharm Bull (Tokyo), 58, 432–4.
   PubMed Web of Science ®Google Scholar
• WERLE, M. & TAKEUCHI, H. (2009) Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation. Int J Pharm, 370, 26–32.
   PubMed Web of Science ®Google Scholar
• WOODLEY, J. F. (1994) Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst, 11, 61–95.
   PubMed Web of Science ®Google Scholar